Resource item

Article 9 Labs Corp. strengthens its board of directors with two independent appointments


PHOENIX, January 4, 2022 / PRNewswire / – Article 9 Labs Corp. (OTCQX: INLB) (the “Company”), a franchisor and operator of vertically integrated cannabis dispensaries that produces premium, award-winning products, today announced that Eric C. Kutscher, Pharmacy. D., MBA, FASHP and Laurent X. Taylor were appointed to its board of directors.

“Eric and Lawrence come from very different backgrounds which will enrich our foundation in several key areas of business growth,” said Andrew Bowden, CEO of Item 9 Labs Corp.

Currently, the Company’s cannabis dispensary franchise brand, Path of Unity., has a store owned by a franchisee operating in Boulder, Colorado, as well as the upcoming opening of a corporate store in Adams County, Colorado, and agreements signed with nearly 20 partners who are at various stages of opening their Unity Rd. stores across Maine, Michigan, New Jersey, and Virginia, among other states. Article 9 Laboratories is the most requested brand with more than 54% of that of Arizona dispensaries, according to LeafLink, and has won more than 20 podiums in Arizona marijuana contest. The Company is on the verge of completing the development of its cultivation site in Nevada, recently started the first phase of the development of its main grow site in Arizona and seeking out dispensary acquisitions to accelerate national growth.

Bowden added, “As we look to expand our products and franchise brands nationwide, their in-depth expertise will be invaluable.

The appointments of Kutscher and Taylor demonstrate the Company’s focus on strengthening its corporate governance through more independent directors.

On Eric C. Kutscher:

Kutscher has over 25 years of experience leading high performing teams and is a thought leader in the delivery of patient-centered healthcare, research, academia and leadership. He began his career in academic psychiatry and pharmacology and progressed to full clinical professor positions at three universities.

In 2013, Kutscher retired from his academic role to pursue leadership and advisory opportunities in the healthcare field. He has consulted with well-known companies such as SpotRx / MedAvail, MeMD, UAMC, UArizona / SinfroniaRx, TribalEM / Tribal Health, San Carlos Apache Healthcare, Pill Nurse, Walgreens, Connections Health Solutions and various law firms. Kutscher is currently Senior Director of Clinical Operations and Pharmacy Services for Arizona Oncology Associates, the state’s largest private oncology firm. Arizona, where he was hired to provide change leadership.

“What attracted me to Item 9 Labs Corp. was their vision and their goal of bringing credibility to the industry with very high quality products and service to help people understand cannabis and all the potential therapeutic benefits beyond a mere recreational effect, “said Kutscher, noting that Unity Rd. targets consumers in new and mature markets, leading with an education-driven approach to guide individuals to the right products. “We have the ability to create industry standards and help people feel comfortable exploring cannabis as a medicine.”

On Laurent X. Taylor:

Taylor brings a diverse perspective to the board, combining in-depth financial expertise, strategy and governance to deliver thoughtful questions and ideas that help make informed decisions. As a senior executive, advisor and board member with over 30 years of business experience, he has guided organizations through complex restructurings, acquisitions, corporate development activities and online transactions. capital totaling more than $ 15 billion. He has extensive knowledge of finance, strategy and operations and has developed strategic, financial, operational and turnaround strategies across multiple industries including casino games, hospitality, manufacturing, aviation, l real estate and retail operations.

Lawrence currently serves on the boards of directors of Barrie House Coffee and CLP Holdings III, LLC. At Barrie House Coffee, he chairs the M&A committee and sits on the strategic planning committee. Previously, he served on the boards of directors and committees (mergers and acquisitions, strategic planning, restructuring, finance and compensation) of several companies. He was also a member of the board of directors and treasurer of the finance and compensation committees of Sojourner Center and a member of the board of directors and treasurer of E Tabs Manufacturing.

“Item 9 Labs Corp. is transforming the cannabis industry by using the franchise model to drive retail growth and bring its products to new markets, ”Taylor said. “It is exciting to see their development and I am honored to work with their leadership team to help strengthen their continued success. “

For more information on Item 9 Labs Corp. and its brands, visit https://investors.item9labscorp.com/.

About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor that provides premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in the best products and user experience across multiple categories of cannabis. The company also offers a unique dispensary franchise model through the national Unity Rd. Retail brand. By removing barriers to entry, franchising provides new and existing dispensary owners the opportunity to leverage the knowledge, resources and ongoing support necessary to thrive in their state in a compliant and successful manner. Item 9 Labs brings industry best practices to national markets through distinctive retail experience, cultivation capabilities, and product innovations. The seasoned management team combines a diverse skill set with in-depth experience in the cannabis industry, franchising and capital markets to lead a new generation of public cannabis companies that deliver transparency, consistency and well-being. The Arizona-based company is currently expanding its operating space to over 640,000 square feet on its 50-acre site, one of Arizona’s largest properties zoned to grow and grow flowers. For more information, visit item9labscorp.com.

Media contact:
Article 9 Laboratories
Jayne levy, vice-president of communications
[email protected]

Investor contact:
Article 9 Labs Corp.
[email protected]
800-403-1140

SOURCE Article 9 Labs Corp.